Hologic rejects over $16 billion take-private proposal from TPG and Blackstone, FT reports

Real-time Estimate Cboe BZX			5-day change	1st Jan Change
62.60 ^USD	+15.33%		+10.39%	-13.53%

Published on 05/27/2025 at 13:19

This article is reserved for members

Unlock the article: REGISTER NOW!

Sector Update: Financial	01:27pm	MT
Sector Update: Health Care	01:21pm	MT
Hologic rejects over $16 billion take-private proposal from TPG and Blackstone, FT reports	01:19pm	RE
Blackstone, TPG Offer $16 Billion to Take Hologic Private	01:10pm	MT
Hologic rejects $16 billion take-private proposal from TPG and Blackstone, Financial Times reports	01:01pm	RE
Blackstone, TPG Offer $16 Billion to Take Hologic Private	01:00pm	MT
Blackstone, TPG Offer to Take Hologic Private in $16 Billion Deal, Financial Times Reports	12:57pm	MT
Blackstone, TPG Offer $16 Billion to Take Hologic Private, Financial Times Reports	12:55pm	MT
TPG And Blackstone Offered $16 Bln To Take Health Group Hologic Private – FT	12:54pm	RE
BNP Paribas Exane Adjusts Price Target on Hologic to $71 From $85, Maintains Outperform Rating	06:30am	MT
Hologic to Present New Data at ASCO 2025 Reinforcing the Practice-Changing Role of the Breast Cancer Index®? Test in Helping to Deliver More Personalized Care to Patients	May. 22	CI
Hologic, Inc. Presents at RBC Capital Markets Global Healthcare Conference 2025, May-20-2025 09:30 AM	May. 20
Stephens Adjusts Hologic Price Target to $70 From $77, Maintains Overweight Rating	May. 13	MT
Hologic Insider Bought Shares Worth $300,760, According to a Recent SEC Filing	May. 09	MT
Morgan Stanley Cuts Price Target on Hologic to $65 From $77, Keeps Equalweight Rating	May. 05	MT
US Equity Indexes Jump Following Strong Jobs Report, Easing China Trade Tensions	May. 02	MT
Citigroup Adjusts Hologic Price Target to $60 From $70	May. 02	MT
Leerink Partners Adjusts Hologic Price Target to $60 From $65	May. 02	MT
Jefferies Adjusts Hologic Price Target to $65 From $78	May. 02	MT
JPMorgan Adjusts Hologic Price Target to $70 From $85	May. 02	MT
Mizuho Securities Adjusts Hologic Price Target to $65 From $75	May. 02	MT
Raymond James Adjusts Hologic Price Target to $71 From $90	May. 02	MT
Evercore ISI Adjusts Hologic Price Target to $62 From $65	May. 02	MT
Analyst recommendations: Amazon, Atlassian, Autozone, Block, Monster Beverage…	May. 02
RBC Cuts Price Target on Hologic to $70 From $75, Keeps Sector Perform Rating	May. 02	MT

Duration

Period

HOLX: Dynamic Chart

Hologic, Inc. is the world leader in the design, manufacturing and marketing of diagnostic products, medical imaging systems and surgical products dedicated to women’s health. Net sales break down by area of application as follows:

– molecular diagnostics (44.2%): rapid diagnostic tests for human diseases detection (sexually transmitted infections, respiratory diseases, viral diseases, infectious diseases, cancers of the cervix and prostate, etc.) and fetal fibronectin;

– breast health (37.8%): digital mammography and breast biopsy solutions and systems;

– gynecological surgery (15.9%): endometrial ablation devices, minimally invasive intervention systems for the hysteroscopic elimination of targeted intrauterine diseases (including fibroids and polyps). The group also offers fluid management systems for use in hysteroscopic procedures;

– bone health (2.1%): bone imaging systems, bone sonometers and osteodensitometers for bone structure and density, and osteoporotic fractures risk assessment.

Net sales break down by source of revenue between sales of products (80.8%) and services (19.2%).

Net sales are distributed geographically as follows: the United States (75%), Europe (13.2%), Asia-Pacific (6.5%) and others (5.3%).

More about the company

Sell